Q3 FY2022 · Quarterly report
November 8, 2022 · 61 pages
Read Ovid Therapeutics Inc.'s results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
Ovid Therapeutics Inc.
2.74
USD
+0.34
(+14.17%)
